7597-81-1

Basic information

• Product Name: 2-(4-Methoxybenzylidene)imino-2-deoxy-1,3,4,6-Tetra-O-acetyl--D-glucopyranose
• Synonyms: 2-(4-Methoxybenzylidene)imino-2-deoxy-1,3,4,6-Tetra-O-acetyl--D-glucopyranose;2-Deoxy-2-[(p-Methoxybenzylidene)aMino]-β-D-glucopyranose 1,3,4,6-Τetraacetate;NSC 108113;NSC 42338;Acetic acid 4,5-diacetoxy-6-acetoxyMethyl-3-[(4-Methoxy-benzylidene)-aMino]-tetrahydro-pyran-2-yl ester;1,3,4,6-Tetra-O-acetyl-2-deoxy-2-[p-methoxybenzylidene(amino)]-β-D-glucopyranose;1,3,4,6-Tetra-O-acetyl-2-Deoxy-2-[[(4-methoxyphenyl)methylene]amino]-β-D-glucopyranose
• CAS NO: 7597-81-1
• Molecular Formula: C₂₂H₂₇NO₁₀
• Molecular Weight: 465.45048
• Product Categories: Carbohydrates & Derivatives
• Mol File: 7597-81-1.mol
• Article Data: 36

Chemical Properties

• Melting Point: 181-183°C
• Boiling Point: 559.3°C at 760 mmHg
• Flash Point: 198.4°C
• Appearance: /
• Density: 1.3g/cm³
• Vapor Pressure: 1.53E-12mmHg at 25°C
• Refractive Index: 1.542
• Storage Temp.: 2-8°C
• Solubility: Chloroform, Ethyl Acetate, Methanol
• PKA: 3.07±0.70(Predicted)
• CAS DataBase Reference: 2-(4-Methoxybenzylidene)imino-2-deoxy-1,3,4,6-Tetra-O-acetyl--D-glucopyranose(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-Methoxybenzylidene)imino-2-deoxy-1,3,4,6-Tetra-O-acetyl--D-glucopyranose(7597-81-1)
• EPA Substance Registry System: 2-(4-Methoxybenzylidene)imino-2-deoxy-1,3,4,6-Tetra-O-acetyl--D-glucopyranose(7597-81-1)

Safety Data

• Hazardous Substances Data: 7597-81-1(Hazardous Substances Data)

Usage

Chemical Properties

White Solid

Uses

2-(4-Methoxybenzylidene)imino-2-deoxy-1,3,4,6-Tetra-O-acetyl-β-D-glucopyranose (cas# 7597-81-1) is a compound useful in organic synthesis.

InChI:InChI=1/C22H27NO10/c1-12(24)29-11-18-20(30-13(2)25)21(31-14(3)26)19(22(33-18)32-15(4)27)23-10-16-6-8-17(28-5)9-7-16/h6-10,18-22H,11H2,1-5H3/b23-10+

Upstream product

• 51471-40-0 2--2-deoxy-D-glucopyranose 
• 108-24-7 acetic anhydride 
• 14131-62-5 D-glucosamine hydrochloride 
• 123-11-5 4-methoxy-benzaldehyde 
• 1078691-95-8 (+)-D-glucosamine hydrochloride 
• 52010-97-6 4-(hydroxylmethyl)benzaldehyde 
• 14131-63-6 D-glucosamine hydrochloride 
• 51471-40-0 6-(hydroxymethyl)-3-[4-methoxybenzylideneamino]tetrahydropyran-2,4,5-triol 
• 35946-64-6 2-deoxy-2-(4-methoxybenzylidene)amino-D-glucose 

Downstream Products

• 17460-45-6 tetra-acetyl glucosamine 
• 5432-46-2 1,3,4,6-tetra-O-acetyl-D-glucosamine hydrochloride 
• 62998-16-7 2-(4-nitrobenzylidene)amino-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose 
• 1438624-31-7 2-(3-nitrobenzylidene)amino-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose 
• 1438624-36-2 2-(4-bromobenzylidene)amino-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose 
• 1438624-41-9 2-(4-dimethylaminobenzylidene)amino-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose 
• 1374661-84-3 (1R)-1-((3aR,5R,6S,7R,7aR)-6,7-bis(4-methoxybenzyloxy)-2-(dimethylamino)-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]thiazol-5-yl)ethanol 
• 1588786-72-4 (E)-4-phenyl-2-((2S,3R,4R,5S,6R)-2,4,5-triacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-3-ylamino)but-3-enoic acid 
• 56644-75-8 1,3,4,6-tetra-O-acetyl-2-deoxy-2-(2,2,2-trichloroacetamido)-β-D-glucopyranose 

Relevant articles and documents

GOLD COMPOSITIONS AND METHODS OF USE THEREOF

Gold compounds and pharmaceutically acceptable salts thereof are disclosed. Certain compounds and salts are active as antibacterial, antifungal, and/or anti-parasitic agents. The disclosure provides pharmaceutical compositions containing the gold compounds. Methods of using the gold compounds to treat bacterial infections are disclosed.

1,8-NAPHTHYRIDINE GLUCOSAMINE DERIVATIVES, THEIR USE IN THE TREATMENT OF MICROBIAL INFECTIONS, AND A METHOD FOR PREPARATION

The present disclosure provides a compound of Formula (I) or any pharmaceutically acceptable salt thereof for use in treating a microbial infection in a subject, a method for preparing the same, and a pharmaceutical composition thereof: (I) wherein R

Rational Design of a DNA-Scaffolded High-Affinity Binder for Langerin

Binders of langerin could target vaccines to Langerhans cells for improved therapeutic effect. Since langerin has low affinity for monovalent glycan ligands, highly multivalent presentation has previously been key for targeting. Aiming to reduce the amoun